Latest news
TransThera wins first China approval in post-FGFR cholangiocarcinoma - AllSciAllSci · Thu, 06 Aug 2026 16:41:13 GMTInSilico Medicine Cayman TopCo Receives NMPA IND Approval for ISM8969/HT-001, Blood-Brain-Barrier-Penetrant NLRP3 Inhibitor Co-Developed with Hygtia Therapeutics Co., Ltd - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 05:21:39 GMTNanjing Leads Biolabs Says Lbl-024 Receives IND Approval From NMPA For Metastatic Colorectal Cancer - tradingview.comtradingview.com · Mon, 03 Aug 2026 01:44:00 GMTKelun-Biotech's Sac-TMT Gains NMPA Review for First-Line Advanced TNBC Indication - BioPharm InternationalBioPharm International · Thu, 30 Jul 2026 17:19:38 GMT